GHRPs (growth hormone releasing peptides) function through two distinct mechanisms: ghrelin agonists that bind G protein-coupled receptors in the pituitary to stimulate pulsatile growth hormone release, and GHRH analogs that work on a different pituitary receptor, allowing synergistic low-dose combinations that reduce side effects while maintaining efficacy.